source
- BD advises recall of sodium chloride ampules in convenience kits after Huons Co. issueThe FDA issued an Early Alert after Becton Dickinson (BD) sent a letter to customers about a potential high‑risk device issue. The alert concerns convenience kits and procedural trays that contain…
- EyePoint’s Phase 3 trial of duravyu fails to outperform aflibercept, shares plunge 70%EyePoint announced that its Phase 3 Lugano trial of the investigational tyrosine kinase inhibitor duravyu did not meet the primary efficacy endpoint when compared with the standard‑of‑care anti‑VEG…